Wellgistics Health, Inc. Common Stock Cash Flow Conversion Efficiency
Wellgistics Health, Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, Wellgistics Health, Inc. Common Stock (WGRX) has a cash flow conversion efficiency ratio of 0.227x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.41 Million) by net assets ($-15.06 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Wellgistics Health, Inc. Common Stock (2022–2025)
Cash flow conversion efficiency of Wellgistics Health, Inc. Common Stock from 2022 to 2025. This chart illustrates how Wellgistics Health, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Wellgistics Health, Inc. Common Stock (WGRX) stock price for real-time trading data and today's change.
Wellgistics Health, Inc. Common Stock Cash Flow Conversion Ratio Explained
Wellgistics Health, Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Wellgistics Health, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wellgistics Health, Inc. Common Stock ranked by their cash flow conversion efficiency. Also see WGRX company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Horizon Gold Ltd
AU:HRN
|
-0.016x |
|
Helloworld Travel Ltd
AU:HLO
|
0.110x |
|
1Stdibs.Com Inc
NASDAQ:DIBS
|
0.013x |
|
Shanghai Longyun Advg & Media
SHG:603729
|
0.031x |
|
Tachan Securities Co Ltd
TWO:6020
|
-0.043x |
|
Mayfair Gold Corp
V:MFG
|
-0.176x |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
|
0.053x |
|
Saniona AB
ST:SANION
|
-0.125x |
Annual Cash Flow Conversion Efficiency for Wellgistics Health, Inc. Common Stock (2022–2025)
The table below shows the annual cash flow conversion efficiency of Wellgistics Health, Inc. Common Stock from 2022 to 2025. Review Wellgistics Health, Inc. Common Stock free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-12.45 Million | $-10.86 Million | 0.872x | +579.41% |
| 2024-12-31 | $6.73 Million | $-1.22 Million | -0.182x | -251.11% |
| 2023-12-31 | $-2.90 Million | $-349.14K | 0.120x | -- |
| 2022-12-31 | $-5.25K | $0.00 | 0.000x | -- |
About Wellgistics Health, Inc. Common Stock
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, … Read more